Closed |
S0215 |
ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Pos Stage IV Breast Cancer |
9/15/2002 |
1/1/2007 |
84% |
|
Published
|
Closed |
S0216 |
SCCHN |
3/1/2003 |
8/19/2004 |
100% |
|
Published
|
Closed |
S0217 |
Adjuvant, locally advanced squamous cell carcinoma |
7/1/2005 |
1/10/2007 |
13% |
|
|
Closed |
S0218 |
Malignant Pleural Mesothelioma |
5/1/2002 |
4/1/2003 |
100% |
|
Published
|
Closed |
S0219 |
Local Bladder |
1/1/2003 |
12/15/2006 |
81% |
|
Published
|
Closed |
S0220 |
Cis/VP-16/RT/Surgery/Doc/Selected IIB, Stage IIIA or IIIB (Pancoast Tumors) |
7/1/2003 |
10/1/2007 |
92% |
|
Published
|
Closed |
S0221 |
ADJUVANT: Continuous Schedule AC + G Vs. Q 2 Week Schedule AC, followed by Paclitaxel |
11/1/2003 |
1/15/2012 |
100% |
|
Published
|
Closed |
S0222 |
TPZ/Cis/VP-16 and RT in Limited SCLC |
9/1/2003 |
7/24/2006 |
63% |
|
Published
|
Closed |
S0224 |
Penile |
10/15/2004 |
11/15/2005 |
5% |
|
|
Closed |
S0226 |
ADVANCED: Anastrozole vs. Anastrozole and Fulvestrant |
4/1/2004 |
7/1/2009 |
100% |
|
Published
|
Closed |
S0227 |
CERVICAL |
4/1/2003 |
7/28/2003 |
0% |
|
|
Closed |
S0229 |
Exercise Intervention |
9/1/2004 |
|
1% |
|
|
Closed |
S0230 |
CANCER CONTROL - Prevention of Ovarian Failure Following Chemotherapy in Early Stage Breast Cancer |
10/1/2003 |
|
56% |
|
Published
|
Closed |
S0232 |
Phase III Double-Blinded Placebo Controlled Previously Untreated Multiple Myeloma |
11/1/2004 |
5/11/2007 |
40% |
|
Published
|
Closed |
S0300 |
CANCER CONTROL - Premenopausal Women at High Risk for Breast Cancer |
11/1/2004 |
5/13/2008 |
8% |
|
|
Closed |
S0301 |
Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older |
10/1/2003 |
12/15/2006 |
100% |
|
Published
|
Closed |
S0303 |
COLORECTAL |
4/1/2004 |
9/1/2004 |
2% |
|
|
Closed |
S0304 |
RECTAL |
8/1/2004 |
2/1/2006 |
0% |
|
|
Closed |
S0306 |
Advanced Bladder |
7/15/2003 |
2/1/2007 |
100% |
|
Published
|
Closed |
S0307 |
ADJUVANT: Bisphosphonates as Adjuvant Therapy for Breast Cancer |
11/15/2005 |
2/1/2010 |
100% |
|
|